Literature DB >> 30108727

Dark chemical matter in public screening assays and derivation of target hypotheses.

Swarit Jasial1, Jürgen Bajorath1.   

Abstract

Compounds that are consistently inactive in many screening assays, so-called dark chemical matter (DCM), have recently experienced increasing attention. One of the reasons is that many DCM compounds may not be fully inert biologically, but may provide interesting leads for obtaining compounds that are highly selective or active against unusual targets. In this study, we have systematically identified DCM among extensively assayed screening compounds and searched for analogs of these compounds that have known bioactivities. Analog series containing DCM and known bioactive compounds were generated on a large scale, making it possible to derive target hypotheses for more than 8000 extensively assayed DCM molecules.

Entities:  

Year:  2017        PMID: 30108727      PMCID: PMC6071712          DOI: 10.1039/c7md00426e

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  25 in total

1.  A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.

Authors:  Susan L McGovern; Emilia Caselli; Nikolaus Grigorieff; Brian K Shoichet
Journal:  J Med Chem       Date:  2002-04-11       Impact factor: 7.446

2.  MMP-Cliffs: systematic identification of activity cliffs on the basis of matched molecular pairs.

Authors:  Xiaoying Hu; Ye Hu; Martin Vogt; Dagmar Stumpfe; Jürgen Bajorath
Journal:  J Chem Inf Model       Date:  2012-04-17       Impact factor: 4.956

Review 3.  Screening in a spirit haunted world.

Authors:  Brian K Shoichet
Journal:  Drug Discov Today       Date:  2006-07       Impact factor: 7.851

4.  Scaffold composition and biological relevance of screening libraries.

Authors:  Anang A Shelat; R Kiplin Guy
Journal:  Nat Chem Biol       Date:  2007-08       Impact factor: 15.040

5.  Drug discovery: A question of library design.

Authors:  Philip J Hajduk; Warren R J D Galloway; David R Spring
Journal:  Nature       Date:  2011-02-03       Impact factor: 49.962

6.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

Authors:  Jonathan B Baell; Georgina A Holloway
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

7.  An Aggregation Advisor for Ligand Discovery.

Authors:  John J Irwin; Da Duan; Hayarpi Torosyan; Allison K Doak; Kristin T Ziebart; Teague Sterling; Gurgen Tumanian; Brian K Shoichet
Journal:  J Med Chem       Date:  2015-08-28       Impact factor: 7.446

8.  Quantification of frequent-hitter behavior based on historical high-throughput screening data.

Authors:  J Willem M Nissink; Sam Blackburn
Journal:  Future Med Chem       Date:  2014-06       Impact factor: 3.808

9.  Chemistry: Chemical con artists foil drug discovery.

Authors:  Jonathan Baell; Michael A Walters
Journal:  Nature       Date:  2014-09-25       Impact factor: 49.962

10.  PubChem's BioAssay Database.

Authors:  Yanli Wang; Jewen Xiao; Tugba O Suzek; Jian Zhang; Jiyao Wang; Zhigang Zhou; Lianyi Han; Karen Karapetyan; Svetlana Dracheva; Benjamin A Shoemaker; Evan Bolton; Asta Gindulyte; Stephen H Bryant
Journal:  Nucleic Acids Res       Date:  2011-12-02       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.